The differences in the involvements of loci of promoter region and ile50val in interleukin-4 receptor α chain gene between atopic dermatitis and Japanese cedar pollinosis

Allergology International

Volumn 61, Issue 1, 2012, Pages 57-63

  Tanaka, Takeshi ^a,b   Hitomi, Yoshiaki ^a   Kambayashi, Yasuhiro ^a   Hibino, Yuri ^a   Fukutomi, Yuma ^a   Shibata, Aki ^a   Sugimoto, Naotoshi ^c   Hatta, Kotaro ^d   Eboshida, Akira ^e   Konoshita, Tadashi ^f   Nakamura, Hiroyuki ^a  

^a Department of Environmental and Preventive Medicine ^*  (Japan)

^b Tanaka Hospital   (Japan)

^c KANAZAWA UNIVERSITY   (Japan)

^d JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e HIROSHIMA UNIVERSITY   (Japan)

^f University of Fukui   (Japan)

Author keywords

Atopic dermatitis; Haplotype; Il 4; Japanese cedar pollinosis; Polymorphism

Indexed keywords

INTERLEUKIN 4 RECEPTOR ALPHA;

ADULT; ARTICLE; ATOPIC DERMATITIS; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; FAMILY; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC ASSOCIATION; GENETIC DIFFERENCE; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HUMAN; JAPANESE CEDAR; JAPANESE CEDAR POLLINOSIS; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; POLLEN ALLERGY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RISK FACTOR; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84863377817     PISSN: 13238930     EISSN: 14401592     Source Type: Journal    
DOI: 10.2332/allergolint.10-OA-0302     Document Type: Article

References (36)

1. Chan LS, Robinson N, Xu L. Expression of interleukin-4 in the epidermis of transgenic mice results in a pruritic inflammatory skin disease: an experimental animal model to study atopic dermatitis. J Invest Dermatol 2001; 117: 977-983.
2. Williams HC. Epidemiology of atopic dermatitis. Clin Exp Dermatol 2000; 25: 522-529.
3. Wuthrich B. Clinical aspects, epidemiology, and prognosis of atopic dermatitis. Ann Allergy Asthma Immunol 1999; 83: 464-470.
4. Kusunoki T, Korematsu S, Nakahata T, Hosoi S. [Cedar pollinosis in Japanese schoolchildren: results from a large questionnaire-based survey]. Arerugi 2002; 51: 15-19(in Japanese).
5. Miyake Y, Yura A, Iki M. Cross-sectional study of allergic disorders in relation to familial factors in Japanese adolescents. Acta Paediatr 2004; 93: 380-385.
6. Leung DY. Atopic dermatitis: immunobiology and treatment with immune modulators. Clin Exp Immunol 1997; 107 (Suppl 1): 25-30.
7. Forrest S, Dunn K, Elliott K et al. Identifying genes predisposing to atopic eczema. J Allergy Clin Immunol 1999; 104: 1066-1070.
8. Miyake Y, Ohya Y, Tanaka K et al. Home environment and suspected atopic eczema in Japanese infants: the Osaka Maternal and Child Health Study. Pediatr Allergy Immunol 2007; 18: 425-432.
9. Kiyohara C, Tanaka K, Miyake Y. Genetic susceptibility to atopic dermatitis. Allergol Int 2008; 57: 39-56.
10. Nakagawa H, Ohashi N, Omura A, Watanabe Y, Teranishi H, Keyaki Y. Clinical manifestations of Japanese cedar pollinosis: an epidemiological study. Rhinology 1996; 34: 201-205.
11. Tanihara S, Oki I, Ojima T, Nakamura Y, Yanagawa H. Process and current status of the epidemiologic studies on cedar pollinosis in Japan. J Epidemiol 1999; 9: 20-26.
12. Nakamura H, Miyagawa K, Ogino K et al. High contribution contrast between the genes of eosinophil peroxidase and IL-4 receptor alpha-chain in Japanese cedar pollinosis. J Allergy Clin Immunol 2003; 112: 1127-1131.
13. Izuhara K, Shirakawa T. Signal transduction via the interleukin-4 receptor and its correlation with atopy. Int J Mol Med 1999; 3: 3-10.
14. Ober C, Leavitt SA, Tsalenko A et al. Variation in the interleukin 4-receptor alpha gene confers susceptibility to asthma and atopy in ethnically diverse populations. Am J Hum Genet 2000; 66: 517-526.
15. Izuhara K, Yanagihara Y, Hamasaki N, Shirakawa T, Hopkin JM. Atopy and the human IL-4 receptor alpha chain. J Allergy Clin Immunol 2000; 106: S 65-71.
16. Mitsuyasu H, Izuhara K, Mao XQ et al. Ile50Val variant of IL4R alpha upregulates IgE synthesis and associates with atopic asthma. Nat Genet 1998; 19: 119-120.
17. Hesselmar B, Bergin AM, Park H et al. Interleukin-4 receptor polymorphisms in asthma and allergy: relation to different disease phenotypes. Acta Paediatr 2010; 99: 399-403.
18. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 1980;92(Suppl): 44-47.
19. Hanifin JM. Diagnostic criteria for atopic dermatitis: consider the context. Arch Dermatol 1999; 135: 1551.
20. Hackstein H, Hecker M, Kruse S et al. A novel polymorphism in the 5' promoter region of the human interleukin-4 receptor alpha-chain gene is associated with decreased soluble interleukin-4 receptor protein levels. Immunogenetics 2001; 53: 264-269.
21. Shirakawa I, Deichmann KA, Izuhara I, Mao I, Adra CN, Hopkin JM. Atopy and asthma: genetic variants of IL-4 and IL-13 signalling. Immunol Today 2000; 21: 60-64.
22. Patient RK, McGhee JD. The GATA family (vertebrates and invertebrates). Curr Opin Genet Dev 2002; 12: 416-422.
23. Kruse S, Japha T, Tedner M et al. The polymorphisms S503P and Q576R in the interleukin-4 receptor alpha gene are associated with atopy and influence the signal transduction. Immunology 1999; 96: 365-371.
24. Mitsuyasu H, Yanagihara Y, Mao XQ et al. Cutting edge: dominant effect of Ile50Val variant of the human IL-4 receptor alpha-chain in IgE synthesis. J Immunol 1999; 162: 1227-1231.
25. Tanaka K, Sugiura H, Uehara M, Hashimoto Y, Donnelly C, Montgomery DS. Lack of association between atopic eczema and the genetic variants of interleukin-4 and the interleukin-4 receptor alpha chain gene: heterogeneity of genetic backgrounds on immunoglobulin E production in atopic eczema patients. Clin Exp Allergy 2001; 31: 1522-1527.
26. Tanaka K, Roberts MH, Yamamoto N et al. Genetic variants of the receptors for thromboxane A2 and IL-4 in atopic dermatitis. Biochem Biophys Res Commun 2002; 292: 776-780.
27. Fanslow WC, Clifford KN, Park LS et al. Regulation of alloreactivity in vivo by IL-4 and the soluble IL-4 receptor. J Immunol 1991; 147: 535-540.
28. Renz H, Bradley K, Enssle K, Loader JE, Larsen GL, Gelfand EW. Prevention of the development of immediate hypersensitivity and airway hyperresponsiveness following in vivo treatment with soluble IL-4 receptor. Int Arch Allergy Immunol 1996; 109: 167-176.
29. Hytonen AM, Lowhagen O, Arvidsson M et al. Haplotypes of the interleukin-4 receptor alpha chain gene associate with susceptibility to and severity of atopic asthma. Clin Exp Allergy 2004; 34: 1570-1575.
30. Hosomi N, Fukai K, Oiso N et al. Polymorphisms in the promoter of the interleukin-4 receptor alpha chain gene are associated with atopic dermatitis in Japan. J Invest Dermatol 2004; 122: 843-845.
31. Novak N, Kruse S, Kraft S et al. Dichotomic nature of atopic dermatitis reflected by combined analysis of monocyte immunophenotyping and single nucleotide polymorphisms of the interleukin-4_interleukin-13 receptor gene: the dichotomy of extrinsic and intrinsic atopic dermatitis. J Invest Dermatol 2002; 119: 870-875.
32. Oyama K. Cutaneous late-phase reaction to environmental antigen in patients with atopic dermatitis. Dermatology 1993; 187: 182-185.
33. Yokozeki H, Takayama K, Katayama I, Nishioka K. Japanese cedar pollen as an exacerbation factor in atopic dermatitis: results of atopy patch testing and histological examination. Acta Derm Venereol 2006; 86: 148-151.
34. Masuda K, Tsujimoto H, Fujiwara S et al. IgE-reactivity to major Japanese cedar (Cryptomeria japonica) pollen allergens (Cry j 1 and Cry j 2) by ELISA in dogs with atopic dermatitis. Vet Immunol Immunopathol 2000; 74: 263-270.
35. Sakaguchi M, Masuda K, Yasueda H, Saito S, DeBoer DJ, Tsujimoto H. IgE reactivity and cross-reactivity to Japanese cedar (Cryptomeria japonica) and cypress (Chamaecyparis obtusa) pollen allergens in dogs with atopic dermatitis. Vet Immunol Immunopathol 2001; 83: 69-77.
36. Spielman RS, McGinnis RE, Ewens WJ. The transmission/disequilibrium test detects cosegregation and linkage. Am J HumGenet 1994; 54: 559-560.